| scholarly article | Q13442814 |
| P2093 | author name string | M Hecker | |
| T Germann | |||
| A Fayyazi | |||
| T Stojanovic | |||
| T Fiebig | |||
| B Lienenlüke | |||
| P2860 | cites work | The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease | Q74583424 |
| Does microcirculation play a role in the pathogenesis of inflammatory bowel diseases? Answers from intravital microscopic studies in animal models | Q77338163 | ||
| Nitric oxide and inflammatory bowel diseases | Q77586534 | ||
| Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha | Q77929272 | ||
| Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide | Q78099489 | ||
| Effects of hydrogen peroxide scavenger Catalase on villous microcirculation in the rat small intestine in a model of inflammatory bowel disease | Q28378210 | ||
| Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1 | Q28570672 | ||
| Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. | Q30322266 | ||
| Chemokines in the inflammatory bowel diseases | Q33760184 | ||
| Crohn's disease: pathogenesis and persistent measles virus infection | Q34059378 | ||
| Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase | Q35356550 | ||
| Role of cell adhesion molecules in inflammatory bowel diseases | Q41491309 | ||
| Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases | Q41659087 | ||
| Cytokines in inflammatory bowel disease | Q41730146 | ||
| Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease | Q41748164 | ||
| Role of interleukin 8 on leucocyte-endothelial cell adhesion in intestinal inflammation | Q42081630 | ||
| The effect of thalidomide and 2 analogs on collagen induced arthritis. | Q42542229 | ||
| Pathogenesis of Crohn's disease | Q47687482 | ||
| Pathophysiological role of nitric oxide in rat experimental colitis. | Q47822714 | ||
| Beneficial effects of local or systemic lidocaine in experimental colitis. | Q51636668 | ||
| An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. | Q53536563 | ||
| Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. | Q53921400 | ||
| Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease | Q56906591 | ||
| Inhibition of IL-12 production by thalidomide | Q61317117 | ||
| Pressure-induced upregulation of preproendothelin-1 and endothelin B receptor expression in rabbit jugular vein in situ : implications for vein graft failure? | Q64978030 | ||
| Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis | Q67706709 | ||
| Hapten-induced model of chronic inflammation and ulceration in the rat colon | Q69942171 | ||
| Roles of ET-1 in endotoxin-induced microcirculatory disturbance in rat small intestine | Q71620278 | ||
| Experimental models of inflammatory bowel disease | Q71737271 | ||
| The metabolic fate of supidimide in the rat | Q71842744 | ||
| Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats | Q71993274 | ||
| Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases | Q72271487 | ||
| Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production | Q73003024 | ||
| Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation | Q73158915 | ||
| Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency | Q73399968 | ||
| Extravasation of leukocytes assessed by intravital microscopy: effect of thalidomide | Q73885192 | ||
| Detrimental effects of octreotide on intestinal microcirculation | Q74008201 | ||
| Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine | Q74036184 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| thalidomide | Q203174 | ||
| colitis | Q2453464 | ||
| P304 | page(s) | 1414-23 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat - role of endothelial cell-leukocyte interaction | |
| P478 | volume | 133 |
| Q28570900 | CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis |
| Q87217605 | Endoluminal ultrasound biomicroscopy as a reliable tool for in vivo assessment of colonic inflammation in rats |
| Q52931543 | Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats. |
| Q58106918 | Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs |
| Q34202877 | Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis |
| Q52933500 | Selective COX-2 inhibition reduces leukocyte sticking and improves the microcirculation in TNBS colitis. |
| Q38413494 | Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease |
| Q33655628 | Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). |
| Q34098863 | Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production |
| Q42318570 | Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease. |
Search more.